Conquer Cancer Recognizes 12 Early-Career Oncologists with Quality Care Symposium Merit Awards

Vicki Kilpatrick
San Diego Skyline

Conquer Cancer, the ASCO Foundation, is pleased to announce the recipients of the 2019 Quality Care Symposium Merit Awards. Conquer Cancer Merit Awards recognize oncology fellows’ and trainees’ high-quality research submitted in abstracts to an ASCO-sponsored or cosponsored meeting. Awardees will present their research at the Symposium, taking place Sept. 6-7 in San Diego. Research presented at the ASCO Quality Care Symposium explores the latest strategies and methods for quantification of patient experience, provider efficiency, clinical outcomes, and quality and safety in cancer care. 

The following individuals are 2019 Quality Care Symposium Merit Award recipients:


Cristiane Decat Bergerot, PhD, MS, BS

City of Hope Comprehensive Cancer Center


Kaitlin M. Christopherson, MD

The University of Texas MD Anderson Cancer Center


Ryan Huey, MD

The University of Texas MD Anderson Cancer Center


Tara L. Kaufmann, MD, MS

Abramson Cancer Center, University of Pennsylvania


Ali Raza Khaki, MD

University of Washington


Anna Mary Brown Laucis, MD, MPhil

University of Michigan Cancer Center


Dan Le, MD, MHA

BC Cancer


Sarah Lee, MD

Cleveland Clinic Taussig Cancer Institute


Ethan B. Ludmir, MD

The University of Texas MD Anderson Cancer Center


Divya Ahuja Parikh, MD

Stanford University School of Medicine


Emily Miller Ray, MD, MPH

UNC Lineberger Comprehensive Cancer Center


Ana I. Velazquez Manana, MD, MS

UCSF Helen Diller Family Comprehensive Cancer Center

The 2019 Conquer Cancer Merits Awards are supported by: 

Anonymous, Agios Pharmaceuticals, Inc., ASCO Employees, Association of Northern California Oncologists, AstraZeneca, Friends and Family of Dr. and Mrs. Ronald Beller, The Berry Family, Dr. and Mrs. Douglas W. Blayney, Breast Cancer Research Foundation®, Bristol-Myers Squibb, Jonathan K. and Cora Y. Cho Charitable Fund, Eisai Inc., Epiphany Partners Inc., Estate of Darla C. Ellis, G1 Therapeutics, GlaxoSmithKline Oncology, Dr. Arti Hurria and Dr. Hyman B. Muss, Ipsen Biopharmaceuticals Inc., Michael Kelley, MD & Elise Hoffman, PharmD, Kidney Cancer Association, Lilly, Loxo Oncology Inc., a wholly owned subsidiary of Eli Lilly and Company, Merck & Co., Inc., Friends and Family of Dr. James B. Nachman, Northern New England Clinical Oncology Society, Dr. Kathleen Pritchard Medicine Professional Corporation, Sarah Cannon Research Institute, Frances A. Shepherd, MD, FASCO, Stephen A. Sherwin, MD, Drs. Rachna and Puneet Shroff, Nizar M. Tannir, MD, TESARO, a GSK Company, and Dr. Michael and Deborah Troner. 

(This listing is current as of August 27, 2019.)